{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T04:09:00Z","timestamp":1792555740900,"version":"4.5.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-024-52601-1","type":"journal-article","created":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T12:02:37Z","timestamp":1727438557000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Cryo-EM structure of small-molecule agonist bound delta opioid receptor-Gi complex enables discovery of biased compound"],"prefix":"10.1038","volume":"15","author":[{"given":"Lin","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuang","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sicen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5640-1896","authenticated-orcid":false,"given":"Chanjuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8273-1338","authenticated-orcid":false,"given":"Chang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiantian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wencheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runduo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9825-0689","authenticated-orcid":false,"given":"Wei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangdong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0284-8377","authenticated-orcid":false,"given":"Jianfeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7204-801X","authenticated-orcid":false,"given":"Zhenhua","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0328-7719","authenticated-orcid":false,"given":"Bowen","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,27]]},"reference":[{"key":"52601_CR1","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/S0165-6147(03)00066-X","volume":"24","author":"SH Snyder","year":"2003","unstructured":"Snyder, S. H. & Pasternak, G. W. Historical review: opioid receptors. Trends Pharm. Sci. 24, 198\u2013205 (2003).","journal-title":"Trends Pharm. Sci."},{"key":"52601_CR2","doi-asserted-by":"publisher","first-page":"4361","DOI":"10.1016\/j.cell.2022.09.041","volume":"185","author":"Y Zhuang","year":"2022","unstructured":"Zhuang, Y. et al. Molecular recognition of morphine and fentanyl by the human mu-opioid receptor. Cell 185, 4361\u20134375 e4319 (2022).","journal-title":"Cell"},{"key":"52601_CR3","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.1038\/s41386-018-0225-3","volume":"43","author":"RJ Valentino","year":"2018","unstructured":"Valentino, R. J. & Volkow, N. D. Untangling the complexity of opioid receptor function. Neuropsychopharmacology 43, 2514\u20132520 (2018).","journal-title":"Neuropsychopharmacology"},{"key":"52601_CR4","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41583-018-0028-x","volume":"19","author":"E Darcq","year":"2018","unstructured":"Darcq, E. & Kieffer, B. L. Opioid receptors: drivers to addiction? Nat. Rev. Neurosci. 19, 499\u2013514 (2018).","journal-title":"Nat. Rev. Neurosci."},{"key":"52601_CR5","doi-asserted-by":"publisher","first-page":"109526","DOI":"10.1016\/j.neuropharm.2023.109526","volume":"232","author":"AT Blaine","year":"2023","unstructured":"Blaine, A. T. & van Rijn, R. M. Receptor expression and signaling properties in the brain, and structural ligand motifs that contribute to delta opioid receptor agonist-induced seizures. Neuropharmacology 232, 109526 (2023).","journal-title":"Neuropharmacology"},{"key":"52601_CR6","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1213\/01.ANE.0000130389.77859.1C","volume":"99","author":"T Horiuchi","year":"2004","unstructured":"Horiuchi, T. et al. The effects of the delta-opioid agonist SNC80 on hind-limb motor function and neuronal injury after spinal cord ischemia in rats. Anesth. Analg. 99, 235\u2013240 (2004).","journal-title":"Anesth. Analg."},{"key":"52601_CR7","doi-asserted-by":"publisher","first-page":"2904","DOI":"10.3389\/fimmu.2019.02904","volume":"10","author":"TK Eisenstein","year":"2019","unstructured":"Eisenstein, T. K. The role of opioid receptors in immune system function. Front Immunol. 10, 2904 (2019).","journal-title":"Front Immunol."},{"key":"52601_CR8","first-page":"9","volume":"9","author":"R Longoni","year":"1998","unstructured":"Longoni, R., Cadoni, C., Mulas, A., Di Chiara, G. & Spina, L. Dopamine-dependent behavioural stimulation by non-peptide delta opioids BW373U86 and SNC 80: 2. Place-preference and brain microdialysis studies in rats. Behav. Pharm. 9, 9\u201314 (1998).","journal-title":"Behav. Pharm."},{"key":"52601_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/164_2016_18","volume":"247","author":"A Saitoh","year":"2018","unstructured":"Saitoh, A. & Nagase, H. Delta opioid receptor (DOR) ligands and pharmacology: development of indolo- and quinolinomorphinan derivatives based on the message-address concept. Handb. Exp. Pharm. 247, 3\u201319 (2018).","journal-title":"Handb. Exp. Pharm."},{"key":"52601_CR10","doi-asserted-by":"crossref","unstructured":"Stevenson, G. W., Folk, J. E., Rice, K. C. & Negus, S. S. Interactions between delta and mu opioid agonists in assays of schedule-controlled responding, thermal nociception, drug self-administration, and drug versus food choice in rhesus monkeys: studies with SNC80 [(+)\u22124-[(alphaR)-alpha-((2S,5R)\u22124-allyl-2,5-dimethyl-1-piperazinyl)\u22123-methoxybenzyl]-N,N-diethylbenzamide] and heroin. J. Pharmacol. Exp. Ther. 314, 221\u2013231 (2005).","DOI":"10.1124\/jpet.104.082685"},{"key":"52601_CR11","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1124\/jpet.119.258640","volume":"372","author":"AE Conibear","year":"2020","unstructured":"Conibear, A. E. et al. A novel G protein-biased agonist at the delta opioid receptor with analgesic efficacy in models of chronic pain. J. Pharm. Exp. Ther. 372, 224\u2013236 (2020).","journal-title":"J. Pharm. Exp. Ther."},{"key":"52601_CR12","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1080\/13543784.2017.1275562","volume":"26","author":"V Spahn","year":"2017","unstructured":"Spahn, V. & Stein, C. Targeting delta opioid receptors for pain treatment: drugs in phase I and II clinical development. Expert Opin. Investig. Drugs 26, 155\u2013160 (2017).","journal-title":"Expert Opin. Investig. Drugs"},{"key":"52601_CR13","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/nature11111","volume":"485","author":"S Granier","year":"2012","unstructured":"Granier, S. et al. Structure of the delta-opioid receptor bound to naltrindole. Nature 485, 400\u2013404 (2012).","journal-title":"Nature"},{"key":"52601_CR14","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/nature12944","volume":"506","author":"G Fenalti","year":"2014","unstructured":"Fenalti, G. et al. Molecular control of delta-opioid receptor signalling. Nature 506, 191\u2013196 (2014).","journal-title":"Nature"},{"key":"52601_CR15","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/nsmb.2965","volume":"22","author":"G Fenalti","year":"2015","unstructured":"Fenalti, G. et al. Structural basis for bifunctional peptide recognition at human delta-opioid receptor. Nat. Struct. Mol. Biol. 22, 265\u2013268 (2015).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"52601_CR16","doi-asserted-by":"publisher","first-page":"eaax9115","DOI":"10.1126\/sciadv.aax9115","volume":"5","author":"T Claff","year":"2019","unstructured":"Claff, T. et al. Elucidating the active delta-opioid receptor crystal structure with peptide and small-molecule agonists. Sci. Adv. 5, eaax9115 (2019).","journal-title":"Sci. Adv."},{"key":"52601_CR17","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.neuropharm.2010.07.010","volume":"60","author":"P Keov","year":"2011","unstructured":"Keov, P., Sexton, P. M. & Christopoulos, A. Allosteric modulation of G protein-coupled receptors: a pharmacological perspective. Neuropharmacology 60, 24\u201335 (2011).","journal-title":"Neuropharmacology"},{"key":"52601_CR18","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.tips.2020.12.005","volume":"42","author":"LM Slosky","year":"2021","unstructured":"Slosky, L. M., Caron, M. G. & Barak, L. S. Biased allosteric modulators: new frontiers in GPCR drug discovery. Trends Pharm. Sci. 42, 283\u2013299 (2021).","journal-title":"Trends Pharm. Sci."},{"key":"52601_CR19","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1016\/j.cell.2020.04.053","volume":"181","author":"LM Slosky","year":"2020","unstructured":"Slosky, L. M. et al. beta-arrestin-biased allosteric modulator of NTSR1 selectively attenuates addictive behaviors. Cell 181, 1364\u20131379 e1314 (2020).","journal-title":"Cell"},{"key":"52601_CR20","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.cell.2022.12.026","volume":"186","author":"Y Wang","year":"2023","unstructured":"Wang, Y. et al. Structures of the entire human opioid receptor family. Cell 186, 413\u2013427 e417 (2023).","journal-title":"Cell"},{"key":"52601_CR21","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/164_2017_42","volume":"247","author":"IJ Dripps","year":"2018","unstructured":"Dripps, I. J. & Jutkiewicz, E. M. Delta opioid receptors and modulation of mood and emotion. Handb. Exp. Pharm. 247, 179\u2013197 (2018).","journal-title":"Handb. Exp. Pharm."},{"key":"52601_CR22","doi-asserted-by":"publisher","first-page":"4165","DOI":"10.1016\/j.molcel.2021.07.033","volume":"81","author":"X Cong","year":"2021","unstructured":"Cong, X. et al. Molecular insights into the biased signaling mechanism of the mu-opioid receptor. Mol. Cell 81, 4165\u20134175 e4166 (2021).","journal-title":"Mol. Cell"},{"key":"52601_CR23","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/s41586-022-05588-y","volume":"613","author":"A Faouzi","year":"2023","unstructured":"Faouzi, A. et al. Structure-based design of bitopic ligands for the micro-opioid receptor. Nature 613, 767\u2013774 (2023).","journal-title":"Nature"},{"key":"52601_CR24","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1021\/acschemneuro.2c00780","volume":"14","author":"Y Huang","year":"2023","unstructured":"Huang, Y., Chen, H., Chen, S. R. & Pan, H. L. Duloxetine and amitriptyline reduce neuropathic pain by inhibiting primary sensory input to spinal dorsal horn neurons via alpha1- and alpha2-adrenergic receptors. ACS Chem. Neurosci. 14, 1261\u20131277 (2023).","journal-title":"ACS Chem. Neurosci."},{"key":"52601_CR25","doi-asserted-by":"publisher","first-page":"eabn7065","DOI":"10.1126\/science.abn7065","volume":"377","author":"EA Fink","year":"2022","unstructured":"Fink, E. A. et al. Structure-based discovery of nonopioid analgesics acting through the alpha(2A)-adrenergic receptor. Science 377, eabn7065 (2022).","journal-title":"Science"},{"key":"52601_CR26","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0014-2999(02)02053-8","volume":"450","author":"M Landi","year":"2002","unstructured":"Landi, M. et al. Modulation of gastric emptying and gastrointestinal transit in rats through intestinal cannabinoid CB(1) receptors. Eur. J. Pharm. 450, 77\u201383 (2002).","journal-title":"Eur. J. Pharm."},{"key":"52601_CR27","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/sj.bjp.0707531","volume":"153","author":"J Guindon","year":"2008","unstructured":"Guindon, J. & Hohmann, A. G. Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain. Br. J. Pharm. 153, 319\u2013334, (2008).","journal-title":"Br. J. Pharm."},{"key":"52601_CR28","doi-asserted-by":"publisher","first-page":"4111","DOI":"10.1021\/acschemneuro.0c00289","volume":"11","author":"P Linciano","year":"2020","unstructured":"Linciano, P. et al. Identification of a potent and selective 5-HT(1A) receptor agonist with in vitro and in vivo antinociceptive activity. ACS Chem. Neurosci. 11, 4111\u20134127 (2020).","journal-title":"ACS Chem. Neurosci."},{"key":"52601_CR29","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1038\/sj.bjp.0704979","volume":"137","author":"V Kayser","year":"2002","unstructured":"Kayser, V., Aubel, B., Hamon, M. & Bourgoin, S. The antimigraine 5-HT 1B\/1D receptor agonists, sumatriptan, zolmitriptan and dihydroergotamine, attenuate pain-related behaviour in a rat model of trigeminal neuropathic pain. Br. J. Pharm. 137, 1287\u20131297, (2002).","journal-title":"Br. J. Pharm."},{"key":"52601_CR30","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1016\/j.pain.2012.03.024","volume":"153","author":"N Urtikova","year":"2012","unstructured":"Urtikova, N. et al. Antinociceptive effect of peripheral serotonin 5-HT2B receptor activation on neuropathic pain. Pain 153, 1320\u20131331 (2012).","journal-title":"Pain"},{"key":"52601_CR31","doi-asserted-by":"publisher","first-page":"3284","DOI":"10.1021\/acschemneuro.8b00739","volume":"10","author":"LB Silenieks","year":"2019","unstructured":"Silenieks, L. B. et al. Evaluation of selective 5-HT(2C) agonists in acute seizure models. ACS Chem. Neurosci. 10, 3284\u20133295 (2019).","journal-title":"ACS Chem. Neurosci."},{"key":"52601_CR32","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/apt.12571","volume":"39","author":"A Shin","year":"2014","unstructured":"Shin, A. et al. Systematic review with meta-analysis: highly selective 5-HT4 agonists (prucalopride, velusetrag or naronapride) in chronic constipation. Aliment Pharm. Ther. 39, 239\u2013253 (2014).","journal-title":"Aliment Pharm. Ther."},{"key":"52601_CR33","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.nbd.2017.07.005","volume":"106","author":"M Santello","year":"2017","unstructured":"Santello, M. et al. The brain-penetrant 5-HT(7) receptor agonist LP-211 reduces the sensory and affective components of neuropathic pain. Neurobiol. Dis. 106, 214\u2013221 (2017).","journal-title":"Neurobiol. Dis."},{"key":"52601_CR34","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.bbr.2011.04.041","volume":"223","author":"A Saitoh","year":"2011","unstructured":"Saitoh, A. et al. The novel delta opioid receptor agonist KNT-127 produces antidepressant-like and antinociceptive effects in mice without producing convulsions. Behav. Brain Res 223, 271\u2013279 (2011).","journal-title":"Behav. Brain Res"},{"key":"52601_CR35","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0014-2999(97)01470-2","volume":"342","author":"M Broccardo","year":"1998","unstructured":"Broccardo, M., Improta, G. & Tabacco, A. Central effect of SNC 80, a selective and systemically active delta-opioid receptor agonist, on gastrointestinal propulsion in the mouse. Eur. J. Pharm. 342, 247\u2013251 (1998).","journal-title":"Eur. J. Pharm."},{"key":"52601_CR36","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1124\/pr.114.008979","volume":"68","author":"L Gendron","year":"2016","unstructured":"Gendron, L., Cahill, C. M., von Zastrow, M., Schiller, P. W. & Pineyro, G. Molecular Pharmacology of delta-Opioid Receptors. Pharm. Rev. 68, 631\u2013700 (2016).","journal-title":"Pharm. Rev."},{"key":"52601_CR37","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/nature19112","volume":"537","author":"A Manglik","year":"2016","unstructured":"Manglik, A. et al. Structure-based discovery of opioid analgesics with reduced side effects. Nature 537, 185\u2013190 (2016).","journal-title":"Nature"},{"key":"52601_CR38","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.tips.2017.08.004","volume":"38","author":"HCS Chan","year":"2017","unstructured":"Chan, H. C. S., McCarthy, D., Li, J., Palczewski, K. & Yuan, S. Designing Safer Analgesics via mu-Opioid Receptor Pathways. Trends Pharm. Sci. 38, 1016\u20131037 (2017).","journal-title":"Trends Pharm. Sci."},{"key":"52601_CR39","first-page":"888","volume":"267","author":"SD Comer","year":"1993","unstructured":"Comer, S. D. et al. Convulsive effects of systemic administration of the delta opioid agonist BW373U86 in mice. J. Pharm. Exp. Ther. 267, 888\u2013895 (1993).","journal-title":"J. Pharm. Exp. Ther."},{"key":"52601_CR40","doi-asserted-by":"publisher","first-page":"e202200269","DOI":"10.1002\/anie.202200269","volume":"61","author":"H Wang","year":"2022","unstructured":"Wang, H. et al. Structure-based evolution of G protein-biased mu-opioid receptor agonists. Angew. Chem. Int Ed. Engl. 61, e202200269 (2022).","journal-title":"Angew. Chem. Int Ed. Engl."},{"key":"52601_CR41","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/s41589-022-01208-y","volume":"19","author":"Q Qu","year":"2023","unstructured":"Qu, Q. et al. Insights into distinct signaling profiles of the microOR activated by diverse agonists. Nat. Chem. Biol. 19, 423\u2013430 (2023).","journal-title":"Nat. Chem. Biol."},{"key":"52601_CR42","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/s41586-023-06804-z","volume":"624","author":"Z Xu","year":"2023","unstructured":"Xu, Z. et al. Ligand recognition and G-protein coupling of trace amine receptor TAAR1. Nature 624, 672\u2013681 (2023).","journal-title":"Nature"},{"key":"52601_CR43","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.jsb.2012.09.006","volume":"180","author":"SH Scheres","year":"2012","unstructured":"Scheres, S. H. RELION: implementation of a Bayesian approach to cryo-EM structure determination. J. Struct. Biol. 180, 519\u2013530 (2012).","journal-title":"J. Struct. Biol."},{"key":"52601_CR44","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nmeth.4193","volume":"14","author":"SQ Zheng","year":"2017","unstructured":"Zheng, S. Q. et al. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Methods 14, 331\u2013332 (2017).","journal-title":"Nat. Methods"},{"key":"52601_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jsb.2015.11.003","volume":"193","author":"K Zhang","year":"2016","unstructured":"Zhang, K. Gctf: Real-time CTF determination and correction. J. Struct. Biol. 193, 1\u201312 (2016).","journal-title":"J. Struct. Biol."},{"key":"52601_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43555-x","volume":"14","author":"J Zhu","year":"2023","unstructured":"Zhu, J. et al. A minority of final stacks yields superior amplitude in single-particle cryo-EM. Nat. Commun. 14, 7822 (2023).","journal-title":"Nat. Commun."},{"key":"52601_CR47","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nmeth.4169","volume":"14","author":"A Punjani","year":"2017","unstructured":"Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290\u2013296 (2017).","journal-title":"Nat. Methods"},{"key":"52601_CR48","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1002\/jcc.20945","volume":"29","author":"S Jo","year":"2008","unstructured":"Jo, S., Kim, T., Iyer, V. G. & Im, W. CHARMM-GUI: a web-based graphical user interface for CHARMM. J. Comput Chem. 29, 1859\u20131865 (2008).","journal-title":"J. Comput Chem."},{"key":"52601_CR49","doi-asserted-by":"publisher","first-page":"7830","DOI":"10.1021\/jp101759q","volume":"114","author":"JB Klauda","year":"2010","unstructured":"Klauda, J. B. et al. Update of the CHARMM all-atom additive force field for lipids: validation on six lipid types. J. Phys. Chem. B 114, 7830\u20137843 (2010).","journal-title":"J. Phys. Chem. B"},{"key":"52601_CR50","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.1021\/ct300400x","volume":"8","author":"RB Best","year":"2012","unstructured":"Best, R. B. et al. Optimization of the additive CHARMM all-atom protein force field targeting improved sampling of the backbone phi, psi and side-chain chi(1) and chi(2) dihedral angles. J. Chem. Theory Comput 8, 3257\u20133273 (2012).","journal-title":"J. Chem. Theory Comput"},{"key":"52601_CR51","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1002\/jcc.20291","volume":"26","author":"D Van Der Spoel","year":"2005","unstructured":"Van Der Spoel, D. et al. GROMACS: fast, flexible, and free. J. Comput Chem. 26, 1701\u20131718 (2005).","journal-title":"J. Comput Chem."},{"key":"52601_CR52","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/s41592-020-0884-y","volume":"17","author":"I Rodriguez-Espigares","year":"2020","unstructured":"Rodriguez-Espigares, I. et al. GPCRmd uncovers the dynamics of the 3D-GPCRome. Nat. Methods 17, 777\u2013787 (2020).","journal-title":"Nat. Methods"},{"key":"52601_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46177-z","volume":"15","author":"C Xu","year":"2024","unstructured":"Xu, C. et al. Specific pharmacological and G(i\/o) protein responses of some native GPCRs in neurons. Nat. Commun. 15, 1990 (2024).","journal-title":"Nat. Commun."},{"key":"52601_CR54","doi-asserted-by":"publisher","first-page":"16257","DOI":"10.1021\/acs.jmedchem.3c01637","volume":"66","author":"Z Miao","year":"2023","unstructured":"Miao, Z. et al. A novel bifunctional muOR agonist and sigma(1)R antagonist with potent analgesic responses and reduced adverse effects. J. Med Chem. 66, 16257\u201316275 (2023).","journal-title":"J. Med Chem."},{"key":"52601_CR55","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/0013-4694(72)90177-0","volume":"32","author":"RJ Racine","year":"1972","unstructured":"Racine, R. J. Modification of seizure activity by electrical stimulation. II. motor seizure. Electroencephalogr. Clin. Neurophysiol. 32, 281\u2013294 (1972).","journal-title":"Electroencephalogr. Clin. Neurophysiol."},{"key":"52601_CR56","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/j.1600-0404.2008.01108.x","volume":"119","author":"R Raedt","year":"2009","unstructured":"Raedt, R. et al. Seizures in the intrahippocampal kainic acid epilepsy model: characterization using long-term video-EEG monitoring in the rat. Acta Neurol. Scand. 119, 293\u2013303 (2009).","journal-title":"Acta Neurol. Scand."},{"key":"52601_CR57","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.1016\/j.neubiorev.2013.10.011","volume":"37","author":"M Levesque","year":"2013","unstructured":"Levesque, M. & Avoli, M. The kainic acid model of temporal lobe epilepsy. Neurosci. Biobehav Rev. 37, 2887\u20132899 (2013).","journal-title":"Neurosci. Biobehav Rev."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-52601-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-52601-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-52601-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T13:05:59Z","timestamp":1727442359000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-52601-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,27]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["52601"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-52601-1","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,27]]},"assertion":[{"value":"8 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8284"}}